Q823Y5 AF NFT

1,4-alpha-glucan branching enzyme GlgB

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeighxncjlbqxw2l4mv2pqergljrhmu7e34e4ns5akhp7mvdhdbe3yi/metadata.json
IPFS of structure file: 
bafybeibo6ld3v4jsx7j5opxxvdirimpgboebesnptsj56tjawd2zkzzvm4/AF-Q823Y5-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x9d7467021Db73aeAa95A2Ab5150B26f506bE6044
First NFT owner address (bech32): 
genesis1n46xwqsakuaw422692632zex75rtuczykapmfp
Current NFT ID #148382 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
148382
Accession (UniProt):
Q823Y5
Name::
1,4-alpha-glucan branching enzyme GlgB
Experimental Method:
Predicted structure
Sequence source:
Chlamydia caviae (strain ATCC VR-813 / DSM 19441 / 03DC25 / GPIC)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q823Y5 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q823Y5|GLGB_CHLCV 1,4-alpha-glucan branching enzyme GlgB OS=Chlamydia caviae (strain ATCC VR-813 / DSM 19441 / 03DC25 / GPIC) OX=227941 GN=glgB PE=3 SV=1 MVERIINSEDISLLISGRQSNPHKFLGIISESSSQDRIILFRPGAHFVAIELQGNIAQATHHHSGIFSLVTPKGTLPHDYRIYHQNGLLAHDPYAFSPLWGEMDSFLFHQGTHYKIYERMGAIPCDVGGILGVLFVVWAPHAQRVSVVGDFNYWNGLVNPLRKVSDSGVWELFIPGLDEGTLYKWELVTASGEVLIKTDPYGKGFDIPPQVTSRVINSDRYTWHDQKWMENRKNTKDQPLAIYEVHVGSWQWDNGRPLGYRELAKRLAQYCKELHYTHVELLPITEHPLNESWGYQVTGYYAPTWRYGSFQDFQFFVDHLHCEGIGVILDWVPGHFPTDSFALASFDGEALYESVDHKDPLHPHWHTYTFDYRCSEVVNFLIGSALFWLDKMHIDGLRVDAVTSMLYLDYGRKAGEWSPNIYGGNENLDAIEFIKHFNSVVHREFPAVLTFAEESTDFPKVTESVDSGGLGFDYKWNLGWMHDTFRYIKVDPIFRSYHHNDLTFSLWYAFNERYLLPLSHDEVVHGKGSLLQKIPGDTWTKFAHMRLLLSYQICQPGKKLVFMGGEFAQWKEWSPDNSLDWHLLDNPYHASLHKCVAKMNALYCELPYFWKGDHKQESFLWVDFKDTKNNVISYYRFSGEDRSSALLCIHHFSSEYFPSYVLHCQGIKTCELLFNSDDISFGGSGKGNRLPILCVDHNIPWGIAIELPPLATLIFQVSF